Study Evaluating Patients With Cystinuria

• Status: Recruiting
• Trial end date: 2022-08-01

Summary

This is an open label, multicentre study, evaluating the safety, tolerability, efficacy, compliance and acceptability of alkalising treatments at long-term in patients with cystinuria.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: Advicenne Pharma
• Treatments: Citric Acid; Potassium Citrate